Inhaled Corticosteroids Plus Tiotropium Compared to Inhaled Corticosteroids Plus Montelukast in Children with Partly Controlled/Uncontrolled Asthma: A Non-Inferiority Trial
Indian Journal of Pediatrics · 2026-05 · 93 (5) · 472-478
DOI: 10.1007/s12098-026-06003-4 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Indian Journal of Pediatrics, online erschienen am 03.03.2026. Verfasst von Soma Sengupta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar, India. Hauptthemen laut MEDLINE: Asthma, Cyclopropanes, Quinolines, Sulfides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
OBJECTIVES: To compare the efficacy and safety of oral montelukast and inhaled tiotropium as add-on drugs to inhaled corticosteroids (ICS) in children with partly controlled/uncontrolled asthma. METHODS: This open-label, parallel-group, non-inferiority, randomized controlled trial was conducted over two-year period in the pediatrics department of a tertiary care teaching institute. Children aged 6 to 14 y with partly controlled/uncontrolled asthma, despite being on step 2 or 3 of treatment as per Global Initiative for Asthma (GINA) 2021, were enrolled. The primary outcome was proportion of children with ACT/c-ACT score >19 at 3 mo. The secondary outcomes were proportion with ACT/c-ACT score >19 at 6 mo, change in lung function and quality of life score, asthma exacerbations, need for rescue therapy, and steroid use during the follow-up at 3 and 6 mo. All adverse events were recorded. RESULTS: A total of 152 participants were enrolled. At 3-mo follow up, 47/73 (64.4%) and 33/66 (50%) children in the montelukast and tiotropium arms respectively, had an Asthma Control Test/ Childhood Asthma Control Test (ACT/c-ACT) score >19. The difference was not statistically significant and the non-inferiority comparison of tiotropium to montelukast was inconclusive. There was no significant difference in any of the secondary outcomes at 3 or 6 mo. One child in the montelukast group developed neuropsychiatric symptoms. No other significant adverse events were noted. CONCLUSIONS: Non-inferiority of tiotropium to montelukast at 3 mo, when added to ICS in children with partly controlled/uncontrolled asthma, with respect to asthma control, was not proven in this trial. No significant difference was noted at 6 mo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar, India.
- Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar, India. rrdas05@gmail.com.
- Department of Pulmonary Medicine & Critical Care, All India Institute of Medical Sciences, Bhubaneswar, India.
- Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, India.
ORCID-Profile: Rashmi Ranjan Das
Zitieren
APA
Sengupta, S., Das, R. R., Gulla, K. M., Kumar, K., Bal, S. K., & Padhy, B. M. (2026). Inhaled Corticosteroids Plus Tiotropium Compared to Inhaled Corticosteroids Plus Montelukast in Children with Partly Controlled/Uncontrolled Asthma: A Non-Inferiority Trial. Indian Journal of Pediatrics, 93(5), 472-478. https://doi.org/10.1007/s12098-026-06003-4
Vancouver
Sengupta S, Das RR, Gulla KM, Kumar K, Bal SK, Padhy BM. Inhaled Corticosteroids Plus Tiotropium Compared to Inhaled Corticosteroids Plus Montelukast in Children with Partly Controlled/Uncontrolled Asthma: A Non-Inferiority Trial. Indian Journal of Pediatrics. 2026;93(5):472-478. doi:10.1007/s12098-026-06003-4
BibTeX
@article{Sengupta2026,
author = {Sengupta, Soma and Das, Rashmi Ranjan and Gulla, Krishna Mohan and Kumar, Ketan and Bal, Shakti Kumar and Padhy, Biswa Mohan},
title = {Inhaled Corticosteroids Plus Tiotropium Compared to Inhaled Corticosteroids Plus Montelukast in Children with Partly Controlled/Uncontrolled Asthma: A Non-Inferiority Trial},
journal = {Indian Journal of Pediatrics},
year = {2026},
volume = {93},
number = {5},
pages = {472--478},
doi = {10.1007/s12098-026-06003-4}
}
EUVIMED